Superworth

Milestone Scientific price to book ratio MLSS

Market value divided by the book value of the company's net assets, since 2011.

Today, Nov 2, 2026
8.2×
10-year median
7.5×
Against its 10-year history
59th
percentile: 0 is its lowest day, 100 its highest
10-year range
2.7× to 175×
Peer median
2.4×

Milestone Scientific's price to book ratio is 8.2× as of Nov 2, 2026.

That is above its ten-year median of 7.5×, close to the middle of its last ten years.

Over that time it ranged from 2.7× in Mar 2018 to 175× in Jun 2020.

The median for 6 medical instruments and supplies stocks of a similar size is 2.4×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far8.2×7.6×18.5×
20258.9×7.6×17.5×
20249.5×5.3×10.8×
20236.8×3.3×9.7×
20222.9×2.8×8.8×
20218.6×5.7×18.2×
20208.5×5.3×175×
201960.0×4.9×73.6×
201811.4×2.7×20.4×
20174.4×3.7×6.5×
20165.6×2.8×8.4×
20154.5×3.3×6.0×
20143.4×2.6×8.5×
20137.5×6.6×13.7×
201210.7×2.1×10.8×
20112.6×2.2×45.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest Milestone Scientific's size, closest first, today.

CompanyPrice to book ratio
MLSSMilestone Scientific8.2×
NEPHNephros2.9×
APTAlpha Pro Tech0.9×
KEQUKewaunee Scientific1.3×
PDEXPro DEX3.7×
UTMDUtah Medical Products1.8×
INFUInfuSystem4.7×
Peer median2.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Milestone Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.